Fri, Dec 26, 2014, 9:08 AM EST - U.S. Markets open in 22 mins.

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • nickwilliams614 nickwilliams614 Apr 22, 2014 1:28 AM Flag

    RECORD SHATTERING CLINICAL TRIAL RESULTS ARE PROOF THAT STEM CELL THERAPY IS ABOUT TO TRANSFORM MEDICINE

    Clinical trial results like the following are proof that Stem Cell Therapy is about to become the most explosive growth area in medicine.

    Trial results prove that Cesca Therapeutics (KOOL) is the most advanced Regenerative Medicine Stem Cell Therapeutics company because they are CONSISTENTLY SUPERIOR to ALL trial results from ALL stem cell therapy trials.

    For example: these results are historical in any field of medicine.

    Cesca therapeutics recently announced record shattering clinical trial results from their 17 patient CLI trial:
    Highlights
    BEFORE treatment, 100% of “No Option” patients required amputation
    12 months AFTER treatment, 82.4% of patients had no amputation
    Pain level BEFORE treatment on a scale of 0 to 10 was SEVERE at 7.8
    Pain level 12 months AFTER treatment was ALMOST NON-EXISTENT at 0.2
    6-minute walking distance BEFORE treatment was 14.5 meters
    6-minute walking distance 12 months AFTER treatment was 157meters
    BEFORE treatment, 11 patients had gangrene with or without ulceration
    12 months AFTER treatment 0 patients had gangrene or ulceration

    NORMAL NEW BLOOD VESSELS WERE REGENERATED AFTER TREATMENT.

    THERE WERE NO ADVERSE SIDE EFFECTS.

    MORE FACTS:

    CESCA’s AMI, Bone Union and Bone Marrow Stem Cell Transplant studies all show similar successes that are well advanced beyond their peers

    If CESCA were trading at ONLY the AVERAGE MARKET CAP of their competitors, CESCA would be selling at $12 per share today.

    CESCA is an outstanding opportunity for JNJ to leap into a leading position in stem cell therapy.

    CESCA shares are oversold, undervalued and trading at less than $2.00 per share. CESCA is likely to be one of the best performing stocks in investor portfolios for the next few years.

    Sentiment: Strong Buy

 
AEGR
21.59Dec 24 1:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Gilead Sciences Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Spectrum Pharmaceuticals, Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST